Article info
Original research
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison
- Correspondence to Dr Jian-Guo He, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167, Beilishi Road, Xicheng District, Beijing 100037, China; hejianguofw{at}163.com
Citation
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison
Publication history
- Received November 27, 2015
- Revised April 24, 2016
- Accepted April 25, 2016
- First published May 17, 2016.
Online issue publication
May 17, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/